Diabetes (Type 2)

The research is being done to test whether the active study drug, sotagliflozin, is safe in patients who have diabetes, kidney disease and who are at risk for cardiovascular events such as heart attack and stroke.

Anticipated date that enrolment will close: June 2019

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Diabetes (Type 2)

We are seeking volunteers for the SURPASS-4 study which is a clinical trial investigating the safety and effectiveness of tirzepatide when taken once weekly compared to insulin taken once daily in people with type 2 diabetes and increased cardiovascular risk.

    Trial phase 

    check
    Non-Drug
    Phase 1
    Phase 2
    Phase 3
    Phase 4
    Diabetes (Type 2)

    We are seeking people with a condition, Diabetic Kidney Disease (DKD), to participate in a study. The study is testing a new way of treating DKD with an drug called "propagermanium".

    Trial phase 

    check
    Non-Drug
    Phase 1
    Phase 2
    Phase 3
    Phase 4